Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jan
21
2022
Written Description Requirement Challenges: Federal Circuit Decision Sheds Light on How Expert Testimony Can Help Mintz
Feb
26
2014
Houston-Based SURGE Accelerator and the Success of Startup Accelerators Mintz
Apr
8
2014
Energy & Environmental Law Update - April 7. 2014 Mintz
Feb
6
2019
OIG Advisory Opinion Allows Smartphone Loan for Needy Patients Taking Digital Drug Mintz
Jun
13
2014
U.S. Supreme Court: Pom’s Mislabeling Suit Against Coke Not Precluded by FDA Regulations - Food and Drug Administration Mintz
Aug
22
2014
Office of Inspector General (OIG) Finds Risk of Abuse in Specialty Pharmacy’s Per-Fill Fee Proposal Mintz
May
31
2022
Potential Pitfalls of Telehealth Prescribing Mintz
Sep
2
2014
The Increasingly Murky World of 340B Drug Discount Program: What’s Next? Mintz
Sep
23
2014
Energy & Environmental Law Update -- September 22, 2014 Mintz
Apr
8
2019
Congress Keeping its Focus on Drug Costs Mintz
Oct
9
2014
Proposed Rule Issued by HHS Office of the Inspector General (OIG) Realigns Its Enforcement Views with Health Care Reform Goals Mintz
Oct
17
2014
The Incredible Shrinking Red Bull Refund: How Should Courts Verify Class Membership? Mintz
Oct
23
2014
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 23, 2014 Mintz
Jan
15
2015
Pharmacy Qui Tam Based On U&C Price Billing Survives Motion to Dismiss Mintz
Jul
1
2019
Pharmaceutical Companies Object to HHS Drug Pricing Disclosure Rule Mintz
Apr
9
2015
Food Labeling, Food Safety and Nutrition Update Mintz
Apr
16
2015
FDA Increasing Scrutiny of Cosmetic Marketing Claims, New Agency Warnings Suggest Mintz
Sep
3
2019
Patent Prosecution and FDA Compliance Expenses May Help Satisfy the ITC’s Domestic Industry Requirement Mintz
Aug
6
2015
Drug Pumps Are Vulnerable to Hacking, FDA Warns Mintz
Sep
26
2019
FTC Identifies Concerns With Plaintiff’s Lawyers Advertisements Concerning Risks Associated With Pharmaceutical Drugs Mintz
Aug
17
2015
First Amendment Protects Truthful Off-Label Speech by Drug Manufacturers Mintz
Sep
11
2015
Legislative Action to Remove Microbeads from Personal Care Products Intensifies Mintz
Oct
31
2019
5 Key Reasons to Ensure Ongoing Compliance with State Distributor Licensing Requirements Mintz
Nov
11
2015
FDA Requests Input on Use of the Term “Natural” for Foods Mintz
Jan
14
2016
Confirmation of New FDA Head May Be Held Up By GE Salmon Labeling Issues Mintz
Jun
28
2023
FDA Opens a Pilot Program to Scrutinize Certain Laboratory Developed Tests, But Will It Generate Sufficient Interest? Mintz
Sep
20
2023
Mintz IRA Update — A Deeper Dive into Other Controversies of the IRA’s Medicare Drug Price Negotiation Program Mintz
Oct
24
2023
Telehealth Update: DEA Extends Flexibility in Prescribing Controlled Substances via Telehealth Through 2024 Mintz
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins